Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-20-023989

Options or other derivatives

  • Chief Medical Officer acquired 18,430 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ordonez Claudia Chief Medical Officer 2020-04-07 Grant or award · Employee Stock Option (right to buy) +18,430 18,430 D: show line 1 in the form
Loading xslF345X03/doc4.xml…